Screening for NAFLD and its severity in type 2 diabetic patients: value of magnetic resonance imaging and outstanding issues.

Binet, Quentin;Hermans, Michel;Lanthier, Nicolas
(2023) Journal of Hepatology — Vol. 78, n° 5, p. e166-e167 (2023)

Files

MAFLDscreeningMRIDiabetesLetterJHepatol.pdf
  • Restricted Access
  • Adobe PDF
  • 131.7 KB
Request a copy

Details

Authors
  • Binet, QuentinUCLouvain
    Author
  • Hermans, MichelUCLouvain
    Author
  • Lanthier, Nicolasorcid-logoUCLouvain
    Author
Abstract
To the Editor: Weread Ajmera et al.’s original manuscript with great interest. Screening for non-alcoholic fatty liver disease (NAFLD) is indeed crucial in the type 2 diabetes population because of the intricate links between insulin resistance and hepatic steatosis. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Binet, Q., Hermans, M., & Lanthier, N. (2023). Screening for NAFLD and its severity in type 2 diabetic patients: value of magnetic resonance imaging and outstanding issues. Journal of Hepatology, 78(5), e166-e167. https://doi.org/10.1016/j.jhep.2022.12.004 (Original work published 2023)